MARKET

ATAI

ATAI

Atai Beckley Inc
NASDAQ
3.770
+0.360
+10.56%
After Hours: 3.750 -0.02 -0.53% 19:45 02/06 EST
OPEN
3.440
PREV CLOSE
3.410
HIGH
3.800
LOW
3.440
VOLUME
4.55M
TURNOVER
--
52 WEEK HIGH
6.75
52 WEEK LOW
1.150
MARKET CAP
1.37B
P/E (TTM)
-4.6337
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATAI last week (0126-0130)?
Weekly Report · 5d ago
H.C. Wainwright Remains a Buy on ATAI Life Sciences (ATAI)
TipRanks · 01/28 17:25
Weekly Report: what happened at ATAI last week (0119-0123)?
Weekly Report · 01/26 10:22
Psychedelic: Analyst initiates Atai Beckley with Buy rating
TipRanks · 01/22 16:35
Analysts Are Bullish on Top Healthcare Stocks: ATAI Life Sciences (ATAI), AstraZeneca (AZN)
TipRanks · 01/21 17:30
ATAI Life Sciences Price Target Announced at $11.00/Share by Guggenheim
Dow Jones · 01/20 14:20
ATAI Life Sciences Initiated at Buy by Guggenheim
Dow Jones · 01/20 14:20
Guggenheim Initiates Coverage On AtaiBeckley with Buy Rating, Announces Price Target of $11
Benzinga · 01/20 14:10
More
About ATAI
AtaiBeckley Inc. is a clinical-stage biotechnology company focused on transforming patient outcomes by developing rapid-acting and convenient mental health treatments. The Company's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 (oral R-MDMA) for social anxiety disorder, which are in Phase 2 clinical development. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for opioid use disorder and TRD. BPL-003 is being developed to produce rapid treatment effects from a single dose, within a two-hour interventional psychiatry treatment paradigm, and with a favorable safety profile. VLS-01 is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) being developed as a potential treatment for people living with treatment-resistant depression (TRD). EMP-01 is an oral formulation of R-MDMA.

Webull offers AtaiBeckley Inc stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.